Cycurion is trading 41.73% up in pre-market at $0.99, after rising from the August 13 close of $0.70; no verified company-specific announcement or overnight catalyst explaining the move was identified.
- The August 20 Nasdaq hearing remains the principal known event; delisting action is stayed while the appeal proceeds.
- Scheduled Q2 earnings coverage exists, but no confirmed results were located.